ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 126 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $419,000 | +6.9% | 286,957 | +3.9% | 0.00% | 0.0% |
Q4 2016 | $392,000 | -13.3% | 276,171 | +7.0% | 0.00% | 0.0% |
Q3 2016 | $452,000 | +4.4% | 258,089 | +1.9% | 0.00% | 0.0% |
Q2 2016 | $433,000 | -11.6% | 253,279 | +1.9% | 0.00% | -50.0% |
Q1 2016 | $490,000 | +4.3% | 248,649 | +0.5% | 0.00% | 0.0% |
Q4 2015 | $470,000 | +8.8% | 247,399 | +9.3% | 0.00% | +100.0% |
Q3 2015 | $432,000 | -59.2% | 226,424 | -0.8% | 0.00% | -66.7% |
Q2 2015 | $1,059,000 | -3.1% | 228,251 | -8.8% | 0.00% | 0.0% |
Q1 2015 | $1,093,000 | +58.4% | 250,151 | +25.7% | 0.00% | +50.0% |
Q4 2014 | $690,000 | -19.3% | 198,951 | -2.5% | 0.00% | -33.3% |
Q3 2014 | $855,000 | -28.6% | 204,137 | -0.0% | 0.00% | -25.0% |
Q2 2014 | $1,197,000 | -13.3% | 204,237 | -6.8% | 0.00% | 0.0% |
Q1 2014 | $1,381,000 | +4.9% | 219,249 | -2.5% | 0.00% | 0.0% |
Q4 2013 | $1,316,000 | +4.9% | 224,969 | -5.5% | 0.00% | 0.0% |
Q3 2013 | $1,255,000 | -32.1% | 238,099 | -0.8% | 0.00% | -33.3% |
Q2 2013 | $1,849,000 | – | 240,085 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |